A simple method to assess estrogen receptor gene (ESR1) amplification in paired biopsies from primary tumor and recurrence in breast cancer patients receiving endocrine therapy
dc.catalogador | pva | |
dc.contributor.author | Maiz, Cristóbal | |
dc.contributor.author | Oddó, David | |
dc.contributor.author | Alfaro, Francisca | |
dc.contributor.author | Villarroel, Alejandra | |
dc.contributor.author | Acevedo, Francisco | |
dc.contributor.author | Pérez Sepulveda, Alejandra | |
dc.contributor.author | Muñiz, Sabrina | |
dc.contributor.author | Silva, Fernando | |
dc.contributor.author | Valdivia, Andrés | |
dc.contributor.author | Merino, Tomas | |
dc.contributor.author | Pinto, Mauricio P. | |
dc.contributor.author | Sánchez, César | |
dc.date.accessioned | 2024-01-19T18:21:50Z | |
dc.date.available | 2024-01-19T18:21:50Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Globally, Breast Cancer (BC) is the leading cause of cancer death among women. About 75% of patients are diagnosed with hormone-dependent tumors and are set to receive Endocrine Therapy (ET) targeting the estrogen receptor. Unfortunately, a significant proportion of these patients develops ET resistance. Still controversial, studies have proposed that Estrogen Receptor-Alpha Gene (ESR1) alterations may underlie ET resistance. Here, we describe the use of a Chromogenic in Situ Hybridization (CISH) assay for the assessment of ESR1 amplification in primary tumors and recurrences. This assay could be a useful clinical tool with therapeutic implications for estrogen receptor positive BC patients. | |
dc.fechaingreso.objetodigital | 2024-05-15 | |
dc.fuente.origen | ORCID-ene24 | |
dc.identifier.doi | 10.26717/bjstr.2020.25.004188 | |
dc.identifier.issn | 2574 -1241 | |
dc.identifier.uri | http://dx.doi.org/10.26717/bjstr.2020.25.004188 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/80809 | |
dc.information.autoruc | Escuela de Medicina; Acevedo Claros, Francisco Nicolas; 0000-0003-3482-7746; 119540 | |
dc.issue.numero | 2 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido completo | |
dc.pagina.final | 19079 | |
dc.pagina.inicio | 19076 | |
dc.revista | Biomedical Journal of Scientific & Technical Research | |
dc.rights | acceso abierto | |
dc.rights.license | Creative Commons Attribution 4.0 International Licens | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | ESR1 | |
dc.subject | Breast cancer | |
dc.subject | Estrogen-receptor amplification | |
dc.subject | Endocrine therapy | |
dc.subject | Endocrine therapy resistance | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.title | A simple method to assess estrogen receptor gene (ESR1) amplification in paired biopsies from primary tumor and recurrence in breast cancer patients receiving endocrine therapy | |
dc.type | artículo | |
dc.volumen | 25 | |
sipa.codpersvinculados | 119540 | |
sipa.trazabilidad | ORCID;2024-01-08 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A simple method to assess estrogen.....pdf
- Size:
- 504.5 KB
- Format:
- Adobe Portable Document Format
- Description: